CNTF通过上调CxCl10预防外层视网膜新生血管形成
本研究在Vldlr-/-和激光诱导脉络膜新生血管(CNV)小鼠模型中,单次玻璃体腔注射重组CNTF或CxCl10,6天后评估新生血管病变。CNTF治疗显著减少外层视网膜和脉络膜新生血管,该效应通过Müller细胞STAT3信号通路上调CxCl10分泌间接介导。
要点
- 玻璃体腔注射重组CNTF可显著减少Vldlr-/-和激光-CNV小鼠模型的新生血管。
- CNTF在Vldlr-/-模型中的治疗效应持久但具有时间敏感性,需在P19前进行玻璃体腔注射。
- CNTF通过激活Müller细胞STAT3信号通路上调CxCl10,间接抑制外层视网膜和脉络膜新生血管。
核心结论
- CNTF通过诱导视网膜Müller细胞分泌CxCl10,间接影响外层视网膜和脉络膜新生血管。
研究设计与样本
- 在Vldlr-/-和激光-CNV小鼠模型中,单次玻璃体腔注射重组CNTF或CxCl10,治疗后6天评估新生血管病变程度。
- 采用定量PCR分析CNTF影响的STAT3下游靶点,并用蛋白质组阵列比较CNTF处理与对照处理的原代Müller细胞条件培养基。
主要发现
- 玻璃体腔注射重组CNTF显著减少Vldlr-/-和激光-CNV小鼠模型的新生血管。
- CNTF在Vldlr-/-模型中的治疗效应持久但具有时间敏感性,需在P19前进行玻璃体腔注射。
- 体外和体内机制研究证实CNTF处理激活Müller细胞STAT3信号通路并上调CxCl10。
- 玻璃体腔注射重组CxCl10在Vldlr-/-和激光-CNV小鼠模型中均显著减少外层视网膜新生血管。
临床怎么用
- CNTF可能通过CxCl10介导的机制为外层视网膜和脉络膜新生血管疾病提供治疗策略。
- CNTF治疗的时间敏感性提示需在特定窗口期内干预以发挥持久疗效。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: Ciliary neurotrophic factor (CNTF) is a well-characterized neurotrophic factor currently in clinical trials for the treatment of macular telangiectasia type II. Our previous work showed that CNTF-induced STAT3 signaling is a potent inhibitor of pathologic preretinal neovascular tuft formation in the mouse model of oxygen-induced retinopathy. In this study, we investigated the effect of CNTF on outer retinal and choroidal angiogenesis and the mechanisms that underpin the observed decrease in outer retinal neovascularization following CNTF treatment. METHODS: In the Vldlr-/- and laser-CNV mouse models, mice received a one-time injection (on postnatal day [P] 12 in the Vldlr-/- model and 1 day after laser in the Choroidal Neovascularization (CNV) model) of recombinant CNTF or CxCl10, and the extent of neovascular lesions was assessed 6 days posttreatment. STAT3 downstream targets affected by CNTF treatment were identified using quantitative PCR analysis. A proteome array was used to compare media conditioned by CNTF-treated and control-treated primary Müller cells to screen for CNTF-induced changes in secreted angiogenic factors. RESULTS: Intravitreal treatment with recombinant CNTF led to significant reduction in neovascularization in the Vldlr-/- and laser-CNV mouse models. Treatment effect in the Vldlr-/- was long-lasting but time sensitive, requiring intravitreal treatment before P19. Mechanistic workup in vitro as well as in vivo confirmed significant activation of the STAT3-signaling pathway in Müller cells in response to CNTF treatment and upregulation of CxCl10. Intravitreal injections of recombinant CxCl10 significantly reduced outer retinal neovascularization in vivo in both the Vldlr-/- and laser-CNV mouse models. CONCLUSIONS: CNTF treatment indirectly affects outer retinal and choroidal neovascularization by inducing CxCl10 secretion from retinal Müller cells.
引用
- Bucher F, Aguilar E, Marra KV, et al. CNTF Prevents Development of Outer Retinal Neovascularization Through Upregulation of CxCl10. Invest Ophthalmol Vis Sci. 2020. PMID: 32780864. doi:10.1167/iovs.61.10.20
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。